UPDATE : Monday, September 7, 2020
상단여백
[News Focus] Abbvie hits back at competitors selling Humira biosimilars in Europe by Lee Han-soo 2019-04-15 15:19
All Invossa products contained 293 cells, Kolon confirms by Jeong Sae-im 2019-04-15 11:31
Invossa license won’t be revoked: Kolon CEO by Jeong Sae-im 2019-04-12 11:40
Regulator, Kolon rebuked for slow response to Invossa problem by Jeong Sae-im 2019-04-11 14:46
Canada OKs Celltrion’s Truxima by Lee Han-soo 2019-04-11 11:33
라인
Patients may file class-action lawsuit against Kolon for mislabeling Invossa by Jeong Sae-im 2019-04-10 14:41
Celltrion, iProgen to co-develop novel antibody-drug conjugates by Lee Han-soo 2019-04-09 16:04
Kolon’s foreign partners await cell analysis results by Jeong Sae-im 2019-04-08 14:28
Kolon Life Science criticized for poor quality control on Invossa by Jeong Sae-im 2019-04-05 12:27
‘Invossa, first treatment to have used cancerous cell lines’ by Jeong Sae-im 2019-04-04 15:24
라인
Celltrion completes patient registration for Humira biosimilar by Lee Han-soo 2019-03-28 18:04
Alteogen wins patent on SC injection formulation for Herceptin biosimilar by Lee Han-soo 2019-03-28 15:04
GC’s US branch opens new plasma collection centers by Lee Han-soo 2019-03-27 10:43
Celltrion licenses out hypertrophic cardiomyopathy treatment to Japan by Lee Han-soo 2019-03-25 15:41
Regulator OKs Medipost’s P1 trial of knee osteoarthritis treatment by Lee Han-soo 2019-03-22 14:22
라인
Samsung Bioepis unveils 3-year follow-up data for Ontruzant by Lee Han-soo 2019-03-22 14:05
'US sales of Truxima imminent' by Jeong Sae-im 2019-03-20 17:59
Samsung BioLogics, Eutilex to develop anti-cancer immunotherapies by Lee Han-soo 2019-03-20 17:18
Samsung Bioepis nullifies patents related to Herceptin in Korea by Lee Han-soo 2019-03-18 15:51
Thea, OliX to cooperate in developing age-related macular degeneration treatment by Lee Han-soo 2019-03-18 12:02
여백
여백
여백
Back to Top